Elevance Renewable Sciences
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
$100m | Series C | ||
N/A | $50.0m | Series D | |
$104m | Series E | ||
N/A | $25.0m | Late VC | |
N/A | $40.3m | Late VC | |
* | N/A | Support Program | |
N/A | $10.3m | Late VC | |
N/A | $18.7m | Late VC | |
* | N/A | Acquisition | |
N/A | $18.0m | Late VC | |
Total Funding | AUD632m |
Related Content
Recent News about Elevance Renewable Sciences
EditElevance Renewable Sciences operates in the specialty chemicals market, focusing on transforming renewable plant oils into high-performance chemicals. The company serves a variety of clients across multiple industries, including cleaning, coatings, oilfield chemicals, and personal care. Elevance leverages a Nobel Prize-winning olefin metathesis catalyst to convert natural oils into a diverse portfolio of products. Their business model revolves around the production and sale of these innovative, bio-based chemicals, which offer superior performance and sustainability compared to traditional petrochemical-based products. Revenue is generated through the direct sale of these specialty chemicals to industrial clients who prioritize high performance and environmental sustainability.
Keywords: renewable, plant oils, high-performance, chemicals, olefin metathesis, bio-based, sustainability, industrial, specialty, innovation.